Annual report [Section 13 and 15(d), not S-K Item 405]

Selected Financial Statement Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details)

v3.26.1
Selected Financial Statement Liabilities - Schedule of Accounts Payable and Accrued Expenses (Details) - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Accounts payable:    
Clinical and regulatory expenses $ 565 $ 452
Professional fees 927 904
Selling expenses 1,721 1,553
Manufacturing costs 1,466 706
Non-employee director compensation 1,018 966
Other vendors 282 594
Total accounts payable 5,979 5,175
Accrued interest payable, related parties 1,474 1,145
Accrued interest payable 5,841 2,874
Accrued expenses:    
Payroll expenses 452 323
Government rebates and other rebates 8,538 7,229
Other accrued expenses 331 180
Total accrued expenses 9,321 7,732
Total accounts payable and accrued expenses $ 22,615 $ 16,926